RhBMP-2 and Intramedullary Fixation in Congenital Pseudarthrosis of the Tibia

Journal of Pediatric Orthopaedics

Volumn 38, Issue 4, 2018, Pages 230-238

  Stephens Richards, B ^a   Anderson, Terrence D ^b  

^a TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

BMP; congenital; intramedullary rod; neurofibromatosis; pseudarthrosis; tibia

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ANKLE RADIOGRAPHY; ARTICLE; BONE GRAFT; CASE STUDY; CHILD; CLINICAL ARTICLE; CONGENITAL PSEUDARTHROSIS; FEMALE; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; INTRAMEDULLARY NAILING; MALE; NEUROFIBROMATOSIS TYPE 1; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SCHOOL CHILD; SURGICAL TECHNIQUE; TIBIA; TIBIA FRACTURE; BONE TRANSPLANTATION; COMPLICATION; INFANT; PRESCHOOL CHILD; PROCEDURES; PSEUDARTHROSIS; RADIOGRAPHY;

ADOLESCENT; BONE MORPHOGENETIC PROTEIN 2; BONE TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; FRACTURE FIXATION, INTRAMEDULLARY; HUMANS; INFANT; MALE; NEUROFIBROMATOSIS 1; PSEUDARTHROSIS; RADIOGRAPHY; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TIBIAL FRACTURES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84973349159     PISSN: 02716798     EISSN: 15392570     Source Type: Journal    
DOI: 10.1097/BPO.0000000000000789     Document Type: Article

References (21)

1. Anticevic D, Jelic M, Vukicevic S. Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphoge-netic protein-7): a case report. J Pediatr Orthop B. 2006;15:220-221.
2. Dohin B, Dahan-Oliel N, Fassier F, et al. Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): early experience. Clin Orthop Relat Res. 2009;467:3230-3238.
3. Fabeck L, Ghafil D, Gerroudj M, et al. Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg Br. 2006;88:116-118.
4. Kujala S, Vahasarja V, Serlo W, et al. Treatment of congenital pseudarthrosis of the tibia with native bovine BMP: a case report. Acta Orthop Belg. 2008;74:132-136.
5. Lee FY, Sinicropi SM, Lee FS, et al. Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A r eport of five cases. J Bone Joint Surg Am. 2006;88:627-633.
6. Richards BS, Oetgen ME, Johnston CE. The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia. A case series. J Bone Joint Surg Am. 2010;92:177-185.
7. Spiro AS, Babin K, Lipovac S, et al. Combined treatment of congenital pseudarthrosis of the tibia, including recombinant human bone morphogenetic protein-2: a case series. J Bone Joint Surg Br. 2011;93:695-699.
8. Das SP, Ganesh S, Pradhan S, et al. Effectiveness of recombinant human bone morpogenetic protein-7 in the management of congenital pseudoarthrosis of the tibia: a randomized controlled trial. Int Orthop. 2014;38:1987-1992.
9. Oetgen ME, Richards BS. Surgical correction of congenital pseudoarthrosis of the tibia: use of the Williams intramedullary rod and recombinant human bone morphogenetic protein-2. Oper Tech Orthop. 2009;19:13-18.
10. Richards BS, Wilkes D, Dempsey M, et al. A radiographic scoring system to assess healing in congenital pseudarthrosis of the tibia. J Pediatr Orthop B. 2015;24:118-122.
11. Kooistra BW, Dijkman BG, Busse JW, et al. The radiographic union scale intibial fractures: reliability and validity. J Orthop Trauma. 2010;24(suppl 1):S81-S86.
12. Whelan DB, Bhandari M, Stephen D, et al. Development of the radiographic union score for tibial fractures for the assessment of tibial fracture healing after intramedullary fixation. J Trauma. 2010; 68:629-632.
13. Khan T, Joseph B. Controversies in the management of congenital pseudarthrosis of the tibia and fibula. Bone Joint J. 2013;95-B: 1027-1034.
14. Stevenson DA, Little D, Armstrong L, et al. Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities Consortium. J Pediatr Orthop. 2013;33:269-275.
15. Dobbs MB, Rich MM, Gordon JE, et al. Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia. A long-term follow-up study. J Bone Joint Surg Am. 2004;86:1186-1197.
16. Johnston CE II. Congenital pseudarthrosis of the tibia: results of technical variations in the Charnley-Williams procedure. J Bone Joint Surg Am. 2002;84:1799-1810.
17. Umber JS, Moss SW, Coleman SS. Surgical treatment of congenital pseudarthrosis of the tibia. Clin Orthop Relat Res. 1982;166: 28-33.
18. Cho TJ, Seo JB, Lee HR, et al. Biologic characteristics in fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1. J Bone Joint Surg Am. 2008;90: 2735-2744.
19. Oetgen MD, Richards BS. Complications associated with the use of bone morphogenetic protein in pediatric patients. J Pediatr Orthop. 2010;30:192-198.
20. Steib JP, Bouchaib J, Walter A, et al. Could an osteoincuctor result in degeneration of a neurofibroma in NF1? Eur Spine J. 2010;19S: S220-S225.
21. Kelly MP, Savage JW, Bentzen SM, et al. Cancer risk from bone morphogenetic protein exposure in spinal arthrodesis. J Bone Joint Surg Am. 2014;96:1417-1422.